BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32320730)

  • 1. Applications of personalised signalling network models in precision oncology.
    Hastings JF; O'Donnell YEI; Fey D; Croucher DR
    Pharmacol Ther; 2020 Aug; 212():107555. PubMed ID: 32320730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building patient-specific models for receptor tyrosine kinase signaling networks.
    Ebata K; Yamashiro S; Iida K; Okada M
    FEBS J; 2022 Jan; 289(1):90-101. PubMed ID: 33755310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-specific Boolean models of signalling networks guide personalised treatments.
    Montagud A; Béal J; Tobalina L; Traynard P; Subramanian V; Szalai B; Alföldi R; Puskás L; Valencia A; Barillot E; Saez-Rodriguez J; Calzone L
    Elife; 2022 Feb; 11():. PubMed ID: 35164900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering.
    Joo JI; Choi M; Jang SH; Choi S; Park SM; Shin D; Cho KH
    Adv Mater; 2020 Sep; 32(35):e1906783. PubMed ID: 32253807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating cancer network attractors for tumor-specific therapy.
    Creixell P; Schoof EM; Erler JT; Linding R
    Nat Biotechnol; 2012 Sep; 30(9):842-8. PubMed ID: 22965061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory healthcare by design: Computational approaches bringing respiratory precision and personalised medicine closer to bedside.
    Kaul H
    Morphologie; 2019 Dec; 103(343):194-202. PubMed ID: 31711740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing system models of cell death signalling for cytotoxic chemotherapy: towards personalised medicine approaches?
    Huber HJ; McKiernan RG; Prehn JH
    J Mol Med (Berl); 2014 Mar; 92(3):227-37. PubMed ID: 24477766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision oncology: origins, optimism, and potential.
    Prasad V; Fojo T; Brada M
    Lancet Oncol; 2016 Feb; 17(2):e81-e86. PubMed ID: 26868357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine.
    Ozturk K; Dow M; Carlin DE; Bejar R; Carter H
    J Mol Biol; 2018 Sep; 430(18 Pt A):2875-2899. PubMed ID: 29908887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-Oriented Approaches to Anticancer Drug Response.
    Lecca P; Re A
    Methods Mol Biol; 2017; 1513():101-117. PubMed ID: 27807833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Systems Biology: a peek into the future of patient care?
    Werner HM; Mills GB; Ram PT
    Nat Rev Clin Oncol; 2014 Mar; 11(3):167-76. PubMed ID: 24492837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Networks and games for precision medicine.
    Biane C; Delaplace F; Klaudel H
    Biosystems; 2016 Dec; 150():52-60. PubMed ID: 27543134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network and systems biology: essential steps in virtualising drug discovery and development.
    Wierling C; Kessler T; Ogilvie LA; Lange BM; Yaspo ML; Lehrach H
    Drug Discov Today Technol; 2015 Aug; 15():33-40. PubMed ID: 26464088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems Medicine in Oncology: Signaling Network Modeling and New-Generation Decision-Support Systems.
    Parodi S; Riccardi G; Castagnino N; Tortolina L; Maffei M; Zoppoli G; Nencioni A; Ballestrero A; Patrone F
    Methods Mol Biol; 2016; 1386():181-219. PubMed ID: 26677185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational oncology--mathematical modelling of drug regimens for precision medicine.
    Barbolosi D; Ciccolini J; Lacarelle B; Barlési F; André N
    Nat Rev Clin Oncol; 2016 Apr; 13(4):242-54. PubMed ID: 26598946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of systems biology to decipher host-pathogen interaction networks and predict biomarkers.
    Dix A; Vlaic S; Guthke R; Linde J
    Clin Microbiol Infect; 2016 Jul; 22(7):600-6. PubMed ID: 27113568
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.